Evidence map›Paper›PMID 42120539›Full record

ArticleEuropean journal of human genetics : EJHG2026

Distinct sub-clusters of developmental disorder-associated variants in the switch II region of RAC1.

Hebah O Althebaiti, James Cooksedge, Martin J Baker, Madeleine Smith, Verity Edwards-Scott, André Luiz Santos Pessoa, Henri Margot, Kay A Metcalfe, Mélanie Fradin, Hailey Mostow and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Hebah O AlthebaitiDivision of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0002-1512-2241
James CooksedgeDivision of Cancer Science, Manchester Cancer Research Centre, University of Manchester, Manchester, UK.
Martin J BakerDivision of Cancer Science, Manchester Cancer Research Centre, University of Manchester, Manchester, UK.
Madeleine SmithDivision of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Verity Edwards-ScottDivision of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID http://orcid.org/0009-0007-2708-4442
André Luiz Santos PessoaFederal University of Ceara, Fortaleza, Brazil.
Henri MargotService de Génétique Médicale, CHU de Bordeaux, Bordeaux, France.ORCID http://orcid.org/0000-0003-1353-0716
Kay A MetcalfeManchester Centre for Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, St Mary's Hospital, Manchester, UK.
Mélanie FradinService de Génétique Clinique, CLAD Ouest, CHU Rennes, Rennes, France.ORCID http://orcid.org/0000-0002-2535-2198
Hailey MostowSt. Christopher's Hospital for Children, Philadelphia, PA, USA.
Marielle AldersAmsterdam UMC, Department of Human Genetics, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7386-4868
Phillis LakemanDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0001-6385-1804
Angeliki MalliriDivision of Cancer Science, Manchester Cancer Research Centre, University of Manchester, Manchester, UK.
Siddharth Banka *Manchester Centre for Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, St Mary's Hospital, Manchester, UK. siddharth.banka@manchester.ac.uk.ORCID http://orcid.org/0000-0002-8527-2210
Tom H Millard *Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. tom.millard@manchester.ac.uk.ORCID http://orcid.org/0000-0002-8869-4654

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RAC1 is a signal transducer essential for neurodevelopment. Missense variants in RAC1 cause heterogeneous neurodevelopmental disorders whose features include intellectual disability and developmental delay. Individuals with RAC1 variants are categorized by head circumference into microcephalic, normocephalic and macrocephalic groups. We previously described a cohort of individuals with variants affecting the N-terminal part (Q61-R68) of switch II, a functional domain of RAC1. This cohort was normocephalic and their variants increased RAC1 signalling activity. Here, we report 15 new individuals with variants in switch II of RAC1. We describe clinical features for two individuals with variants affecting the N-terminal part of switch II (Q61-R68) and four individuals with variants in its C-terminal part (P69-Q74). All individuals exhibit intellectual disabilities and neuroradiological anomalies. Consistent with our previous study, individuals with variants in the N-terminal part of switch II were normocephalic. By contrast, individuals with variants in the C-terminal part of switch II exhibited microcephaly. Cell-based assays revealed that N- and C-terminal variants affect RAC1 function differently: N-terminal variants are activating, while C-terminal variants are dominant-negative. In a Drosophila model, we observe divergent effects on neuronal morphology, with switch II N-terminal variants increasing the complexity of dendritic arbors, while switch II C-terminal variants reduce dendritic complexity. Switch II N-terminal variants increase locomotor activity of adult Drosophila, while C-terminal variants had minimal effect, suggesting diverging effects on neuronal function and behaviour. We conclude that variants affecting N- and C-terminal parts of RAC1 switch II cause phenotypically and mechanistically distinct disorders.

Identifiers

PMID42120539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.